These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 19916727

  • 21. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV, Shane-McWhorter L, Raparla S.
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels.
    Penfornis A, Horvat K.
    Diabetes Technol Ther; 2008 Oct; 10(5):359-62. PubMed ID: 18715211
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M, Bell D, Jacobsen C, Suwannasari R, FlexPen Study Team.
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.
    Brunton S.
    Diabetes Technol Ther; 2008 Aug; 10(4):247-56. PubMed ID: 18715198
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.
    Pfützner A, Asakura T, Sommavilla B, Lee W.
    Expert Opin Drug Deliv; 2008 Aug; 5(8):915-25. PubMed ID: 18713000
    [Abstract] [Full Text] [Related]

  • 33. Lipoatrophy with insulin analogues in type I diabetes.
    Babiker A, Datta V.
    Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Analysis of "Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen".
    Bariya M, Nayberg I.
    J Diabetes Sci Technol; 2018 Mar; 12(2):373-375. PubMed ID: 29281890
    [Abstract] [Full Text] [Related]

  • 38. Dose accuracy testing of the humalog/ humulin insulin pen device.
    Roe MJ, Ignaut D, Miyakawa T, Hultman C.
    Diabetes Technol Ther; 2001 Mar; 3(4):623-9. PubMed ID: 11911175
    [Abstract] [Full Text] [Related]

  • 39. Differences in the dose accuracy of insulin pens.
    Hänel H, Weise A, Sun W, Pfützner JW, Thomé N, Pfützner A.
    J Diabetes Sci Technol; 2008 May; 2(3):478-81. PubMed ID: 19885213
    [Abstract] [Full Text] [Related]

  • 40. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
    Rave K, Heise T, Weyer C, Herrnberger J, Bender R, Hirschberger S, Heinemann L.
    Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.